tiprankstipranks
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
Holding FHTX?
Track your performance easily

Foghorn Therapeutics (FHTX) Income Statement

116 Followers

Foghorn Therapeutics Income Statement

Last quarter (Q3 2024), Foghorn Therapeutics's total revenue was $7.81M, a decrease of -55.33% from the same quarter last year. In Q3, Foghorn Therapeutics's net income was $-19.12M. See Foghorn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.52M$ 34.16M$ 19.23M$ 1.32M$ 430.00K$ 0.00
Cost of Revenue
------
Gross Profit
$ 25.52M$ 34.16M$ 19.23M$ 1.32M$ 430.00K-
Operating Expense
$ 129.65M$ 142.06M$ 136.37M$ 102.05M$ 68.96M$ 51.08M
Operating Income
$ -104.14M$ -107.91M$ -117.14M$ -100.73M$ -68.53M$ -51.08M
Net Non Operating Interest Income Expense
$ 11.46M$ 10.88M$ 5.67M$ -1.85M$ -979.00K$ -45.00K
Other Income Expense
$ 693.00K$ 2.83M$ 2.58M$ -1.26M$ -710.00K$ 1.00K
Pretax Income
$ -89.24M$ -94.20M$ -108.88M$ -101.32M$ -68.80M$ -51.13M
Tax Provision
$ 1.96M$ 4.23M----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -91.96M$ -98.43M$ -108.88M$ -101.32M$ -68.80M$ -51.13M
Basic EPS
$ -1.92$ -2.34$ -2.62$ -2.73$ -6.23$ -2.60
Diluted EPS
$ -1.92$ -2.34$ -2.62$ -2.73$ -6.23$ -2.60
Basic Average Shares
$ 198.85M$ 41.97M$ 41.59M$ 37.17M$ 11.05M$ 19.63M
Diluted Average Shares
$ 198.85M$ 41.97M$ 41.59M$ 37.17M$ 11.05M$ 19.63M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 129.65M$ 142.06M$ 136.37M$ 102.05M$ 68.96M$ 51.08M
Net Income From Continuing And Discontinued Operation
$ -91.18M$ -98.43M$ -108.88M$ -101.32M$ -68.80M$ -51.13M
Normalized Income
$ -56.76M$ -74.42M---$ -51.13M
Interest Expense
-----$ 540.00K
EBIT
$ -90.06M$ -107.91M$ -117.14M$ -99.41M$ -67.82M$ -50.59M
EBITDA
$ -87.25M$ -104.45M$ -113.82M$ -96.03M$ -66.52M$ -49.90M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis